Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open‐label, controlled trial (DIrecT Study)
Tomonori Yamanishi; Hirotaka Asakura; Narihito Seki; Shoji Tokunaga
Author Information: Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.